Whijae Roh - Concepedia

Concepedia

Author

Whijae Roh

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

Roh, Whijae, Whijae Roh

117

Publications

4.7K

Citations

15

H-Index

33

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Broad Institute Harvard University Baylor College of Medicine Parker Institute for Cancer Immunotherapy

WR

About

Whijae Roh is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, immunology, and tumor immunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	2.4K
2	Immunology	3	3	1.3K
3	Microbiology	2	2	399
4	Health Sciences	1	1	388
5	Cell Biology	1	1	902

Whijae Roh

×

16

Publications

4.7K

Citations

15

H-Index

	Year	Citations
Clonal evolution in breast cancer revealed by single nucleus genome sequencing Yong Wang, Jill Waters, Marco L. Leung, Nature ChromatinBreast OncologyTumor HeterogeneityClonal EvolutionGenetics	2014	1.1K
Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade Pei-Ling Chen, Whijae Roh, Alexandre Reuben, Cancer Discovery	2016	971
Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance Whijae Roh, Pei-Ling Chen, Alexandre Reuben, Science Translational Medicine T-regulatory CellImmunologyPathologyImmune Checkpoint BlockadeImmunotherapy	2017	902
<i>CXCL9:SPP1</i> macrophage polarity identifies a network of cellular programs that control human cancers Ruben Bill, Pratyaksha Wirapati, Marius Messemaker, Science	2023	523
Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade Miles C. Andrews, Connie P.M. Duong, Vancheswaran Gopalakrishnan, Nature Medicine DysbiosisHealth SciencesMucosal ImmunologyPd-1 BlockadeMedicine	2021	388
The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses Ferroptosis Xin Hong, Whijae Roh, Ryan J. Sullivan, Cancer Discovery	2020	217
Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma Alexandre Reuben, Christine N. Spencer, Peter A. Prieto, npj Genomic Medicine	2017	187
A Preexisting Rare <i>PIK3CA</i> E545K Subpopulation Confers Clinical Resistance to MEK plus CDK4/6 Inhibition in <i>NRAS</i> Melanoma and Is Dependent on S6K1 Signaling Gabriele Romano, Pei-Ling Chen, Ping Song, Cancer Discovery	2018	93
The Natural Anticancer Agent Plumbagin Induces Potent Cytotoxicity in MCF-7 Human Breast Cancer Cells by Inhibiting a PI-5 Kinase for ROS Generation Ju‐Hee Lee, Ji-Hyun Yeon, Hanna Kim, PLoS ONE	2012	77
Multiomics profiling of primary lung cancers and distant metastases reveals immunosuppression as a common characteristic of tumor cells with metastatic plasticity Won‐Chul Lee, Alexandre Reuben, Xin Hu, Genome biology	2020	61

Page 1